Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/81860
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Discovery of (E)-3-((Styrylsulfonyl) methyl) pyridine and (E)-2-((Styrylsulfonyl) methyl) pyridine Derivatives as Anticancer Agents: Synthesis, Structure–Activity Relationships, and Biological Activities
Author: Lu, T.
Goh, A.W.
Yu, M.
Adams, J.
Lam, F.
Teo, T.
Li, P.
Noll, B.
Zhong, L.
Diab, S.
Chahrour, O.
Hu, A.
Abbas, A.
Liu, X.
Huang, S.
Sumby, C.
Milne, R.
Midgley, C.
Wang, S.
Citation: Journal of Medicinal Chemistry, 2014; 57(6):2275-2291
Publisher: American Chemical Society
Issue Date: 2014
ISSN: 0022-2623
1520-4804
Statement of
Responsibility: 
Tiangong Lu, Aik Wye Goh, Mingfeng Yu, Julian Adams, Frankie Lam, Theodosia Teo, Peng Li, Ben Noll, Longjin Zhong, Sarah Diab, Osama Chahrour, Anran Hu, Abdullahi Y. Abbas, Xiangrui Liu, Shiliang Huang, Christopher J. Sumby, Robert Milne, Carol Midgley, and Shudong Wang
Abstract: ON01910.Na is a highly effective anticancer agent that induces mitotic arrest and apoptosis. Clinical studies with ON01910 in cancer patients have shown efficacy along with an impressive safety profile. While ON01910 is highly active against cancer cells, it has a low oral availability and requires continuous intravenous infusion or multiple gram doses to ensure sufficient drug exposure for biological activity in patients. We have identified two novel series of styrylsulfonyl-methylpyridines. Lead compounds 8, 9a, 18 and 19a are highly potent mitotic inhibitors and selectively cytotoxic to cancer cells. Impressively, these compounds possess excellent pharmaceutical properties and two lead drug candidates 9a and 18 demonstrated antitumor activities in animal models.
Keywords: Cell Line, Tumor; Microsomes, Liver; Animals; Mice; Rats; Sulfonamides; Aminopyridines; Styrenes; Sulfones; Glycine; Annexin A5; Antineoplastic Agents; Indicators and Reagents; Crystallography, X-Ray; Magnetic Resonance Spectroscopy; Area Under Curve; Xenograft Model Antitumor Assays; Cell Cycle; Apoptosis; Cell Proliferation; Structure-Activity Relationship; Biological Availability; Drug Design; Models, Molecular; Half-Life; Mass Spectrometry; Drug Discovery; Kaplan-Meier Estimate
RMID: 0030000193
DOI: 10.1021/jm4019614
Appears in Collections:Chemistry publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.